National Institutes of Health news from FiercePharma
NewsAvastin-Lucentis trial may reshape pharma
We thought the head-to-head trial of Avastin and Lucentis for age-related macular degeneration was a big deal for Genentech, which Read more...
ALSO NOTED: FDA panel to mull Celebrex safety for kids; Sanofi makes deal to sell Lilly drug;
> After waiting for nearly a month, officials at the National Institutes of Health alerted some 2,500 people that their names, addresses and detailed personal health information gathered from Read more...
ALSO NOTED: Canadian courts swamped by patent cases; Government to eye small firms for off-label pitches;
> Drug-patent cases are clogging Canadian courts, with some 30 judges assigned to 350 cases that involve highly specialized, technical knowledge. Read more...
SPOTLIGHT: NIH starts Tykerb vs. Herceptin bout
It's a head-to-head matchup. The National Institutes of Health has launched an 8,000-patient trial pitting GlaxoSmithKline's Tykerb against Genentech's Herceptin in aggressive breast cancer. Read more...
NIH launches Avastin-Lucentis trial
Gentlemen (and ladies), start your eye injections. In other Avastin news, the big trial pitting the cancer drug against Genentech sister med Lucentis is now underway. Sponsored by the National Read more...
Why should Medicare pay for Lucentis?
The U.S. Senate wants to know why Medicare should have to spend millions on Genentech's eye drug Lucentis when the company's Avastin Read more...
NIH unveils new asthma guidelines
New asthma treatment guidelines could be good news for drug companies. The government advises better day-to-day control of the disease--and that probably means more widespread use of inhaled Read more...
| Press ReleasesPRESS RELEASE: NIH director invests in innovation, new investigators NIH director invests in innovation, new investigators This is the first group of New Innovator Awards and the fourth group of Pioneer Awards. Both programs are part of an NIH Roadmap for Read more... PRESS RELEASE: $21.8 Million NIH Grant for Fragile X Research $21.8 Million NIH Grant for Fragile X Research SAN FRANCISCO, Sept. 6 PRNewswire — A team of researchers at the University of California, Davis, School of Medicine and the M.I.N.D. Institute, in Read more... NIH: National Asthma Guidelines Updated National Asthma Guidelines Updated New Approaches for Monitoring Asthma Control, Expanded Recommendations for Children The National Asthma Education and Prevention Program (NAEPP) today issued the Read more... |
Get more National Institutes of Health coverage at:
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends